Human-derived NLS enhance the gene transfer efficiency of chitosan by Bitoque, Diogo B et al.
Human-derived NLS enhance the gene transfer efficiency of chitosan 
 
Diogo B. Bitoque1,2*, Joana Morais3*, Ana V. Oliveira3*, Raquel L. Sequeira1, Sofia M. 
Calado4, Tiago M. Fortunato3, Sónia Simão3, Ana M. Rosa da Costa2, Gabriela A. 
Silva1# 
1 CEDOC, NOVA Medical School, Universidade Nova de Lisboa, Campo dos Mártires 
da Pátria, 130, 1169-056 Lisboa, Portugal 
2Algarve Chemistry Research Centre (CIQA), University of Algarve, Faro, Portugal 
 
3Centre for Biomedical Research (CBMR), University of Algarve, Campus Gambelas, 
8005 Faro, Portugal 
 
*Equally contributing authors 
# Corresponding author: Gabriela A. Silva. email: gabriela.silva@nms.unl.pt. Tel.: 




Nuclear import is considered one of the major limitations for non-viral gene delivery 
systems and the incorporation of nuclear localization signals (NLS) that mediate nuclear 
intake can be used as a strategy to enhance internalization of exogenous DNA. 
In this work, human-derived endogenous NLS peptides based on Insulin Growth Factor 
Binding Proteins (IGFBP), namely IGFBP-3 and IGFBP-5, were tested for their ability to 
improve nuclear translocation of genetic material by non-viral vectors. Several strategies 
were tested to determine their effect on chitosan mediated transfection efficiency: co-
administration with polyplexes, co-complexation at the time of polyplex formation, and 
covalent ligation to chitosan. Our results show that co-complexation and covalent ligation 
of the NLS peptide derived from IGFBP-3 to chitosan polyplexes yields a 2-fold increase 
in transfection efficiency, which was not observed for NLS peptide derived from IGFBP-
5. 
These results indicate that the integration of IGFBP-NLS-3 peptides into polyplexes has 
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Gene therapy entails the transfer of therapeutic genetic material into cells where the 
production of the encoded protein will occur to treat or prevent a disease, by replacement 
of a missing or defective gene [1-4]. Gene therapy is a promising strategy for the 
treatment of many genetic and acquired diseases [2, 5]. Therefore, its success requires 
a gene delivery system with minimal toxicity, capable of protecting its load from 
degradation until it reaches its target, and allowing prolonged and stable gene expression 
[3, 6]. 
Non-viral gene delivery systems based on polyplexes have been considered a safe 
alternative to viral vectors due to their low toxicity, lack of significant immune response, 
ability to be administered repeatedly, low cost, and capacity to package large plasmids 
[7]. Nevertheless, the obstacles at the intracellular level [8] that hinder transfection 
efficiency are the major challenge for polymer-based gene therapy. For a successful 
gene delivery, polyplexes must efficiently enter the cell and traffic through the 
intracellular milieu towards the nucleus, overcoming biological barriers such as plasma, 
endosomal, and nuclear membranes [9]. We have previously explored the gene delivery 
properties of chitosan and hyaluronic acid [10-14] and confirmed the cause of the low 
transfection efficiency to be the inability of the polyplex/DNA load to enter the nucleus. 
To overcome these obstacles, we have explored chemical modification of the vectors 
[10, 12] as a strategy to increase the gene transfer efficiency. In this work, we evaluate 
the efficiency of transfection of our chitosan-based vectors after the incorporation of 
nuclear localization signals (NLS). 
NLS are cationic peptide sequences that consist of either one or two stretches of basic 
amino acids of arginine/lysine and recognized by importins that direct their transport into 
the nucleus [4, 15]. NLS bind either directly to importin-β or to the adapter protein 
importin-α which, in turn, binds to importin-β and forms a complex. The resulting complex 
binds to the nuclear pore complex (NPC), by association with its cytoplasmic filaments, 
and is translocated through the pore to the nucleus. Finally, the complex dissociates and 
importins are recycled back to the cytoplasm, becoming available for a next import cycle 
[8, 16-18]. 
The use of NLS for non-viral gene therapy has been investigated due to the inefficient 
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cells, where in the absence of mitosis there is no disintegration of nuclear membrane 
and nuclear entrance can only occur through the nuclear pore [19-21]. Regarding NLS 
efficiency in the nuclear transport of DNA, it has been found to be influenced by both the 
size and type of DNA (linear or plasmid), the method used for the incorporation of NLS 
(covalent or non-covalent attachment of NLS to DNA or polymer), and type of polymer 
used [15, 22]. 
Insulin-like growth factor binding proteins (IGFBPs) are a family of six mammalian 
multifunctional proteins [23, 24], which are involved in the regulation and transport of 
insulin-like growth factors IGF-I and IGF-II [23, 25]. Site-specific mutagenesis has 
revealed that the C-terminal region of both IGFBP-3 and IGFBP-5 (Table I), contains a 
domain with strong homology with known NLS sequences [23, 24, 26]. Mutations in this 
sequence lead to a reduction of nuclear accumulation [26, 27], suggesting that this 18 
amino acid-long region of IGFBP-3 and IGFBP-5 is essential and sufficient for nuclear 
uptake and accumulation of IGFBP-3 and IGFBP-5 in several cell lines [23, 24, 26]. 
These IGFBP peptides were already used to successfully deliver heterologous proteins, 
such as Glutathione S-transferase (GST) [28]; however, to the best of our knowledge, 
they have never been tested for gene delivery. For several years viral nuclear localization 
signals such as SV40 and TAT peptides [29, 30] have been combined with non-viral 
delivery systems. To avoid viral components in nonviral vectors and decrease the 
possible trigger of an immune response, we have chosen the IGFBPs peptides. 
In this context, our aim was to incorporate NLS derived from IGFBPs into chitosan 
polyplexes to overcome the nuclear barrier and enhance nuclear internalization of DNA, 
thus increasing gene expression. We have tested three strategies to incorporate NLS 
into the formulations: co-administration of NLS and polyplexes, covalent ligation of NLS 
to chitosan, and co-complexation at time of polyplex formation. The polyplexes were 
extensively characterized regarding their size, polydispersity, charge, efficiency of DNA 
complexation, and cytotoxicity. We have found that the transfection efficiency of NLS-
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A plasmid encoding the enhanced green fluorescent protein (eGFP) driven by the 
cytomegalovirus (CMV) promoter (pCMVeGFP) with the ampicillin resistance gene, was 
used for polyplex production. pCMVIGFBP-3 and pCMVIGFBP-5, driven by the CMV 
promoter were used to produce the NLS peptides derived from IGFBP-3 and IGFBP-5, 
respectively (Table I) containing a histidine tag (six residues) at the N-terminal. 
The plasmids were amplified in Top10 E. coli bacteria (as described in section 2.1) and 
extracted using a Plasmid Maxi kit (Qiagen, Germany), according to the manufacturer’s 
instructions. Plasmids were later dissolved in TE buffer and their concentration was 
determined at 260 nm using a NanoDrop 2000c spectrophotometer (Thermo Scientific, 
USA). 
 
Table I - NLS sequences derived from the C-terminal region of IGFBP-3 (NLS-3) and 









Ultrapure chitosan (CS), with MW of 80 kDa and degree of deacetylation of 83%, was 
purchased from Novamatrix (CL 113, FMC BioPolymer AS, Norway). Polymer solutions 
of 1 mg/ml were prepared by dissolving the polymer in ddH2O, and the pH of the 
solutions adjusted to 5.5 with sodium hydroxide. All solutions were sterile filtered 
through a 0.2 m filter. 
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1.3. Cell culture 
 
The HEK293T cell line was used for the transfection assays. Cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM), containing 10% fetal bovine serum (FBS), 
1% glutamine and 1% penicillin/streptomycin solution, and maintained at 37°C under a 






2.1. Bacterial transformation 
 
For bacterial transformation, E. coli TOP 10 bacteria were thawed and kept on ice and 
transformed by heat shock at 42ºC for 90 seconds using 30 ng of plasmid (pCMVIGFBP-
3 or pCMVIGFBP-5) Afterwards, 300 µl of SOC medium (98% tryptone, yeast extract 
and NaCl, 1% of Mg2+ and 1% of glucose) was added and the bacterial suspension was 
incubated at 37ºC for 30 minutes under constant stirring (180 rpm). The transformed 
bacteria (100 µl) were spread in pre-warmed LB agar plates containing kanamycin (30 
µg/ml) and incubated overnight at 37ºC. 
 
2.2. NLS peptide production and purification 
 
The IGFBP-derived NLS peptides (NLS-3 and NLS-5) were extracted from the bacteria 
using the B-Per 6xHis Fusion Protein Purification Kit (Thermo Scientific, USA), according 
to manufacturer’s instructions, and quantified by the Bradford method [31]. 
Thereafter, the NLS peptides were twice dialyzed (first against 10 mM HCl solution for 
6 hours and then against ddH2O water for 12 hours) in dialysis tubing with a 2 kDa MW 
cut-off (Sigma-Aldrich, St. Louis, MO/USA). After dialysis, the NLS peptide solutions 
were frozen at -80ºC and freeze-dried. Concentrations were further determined by 
spectrophotometry at 280 nm, using the molar extinction coefficient obtained from a 
calculation tool made available by Innovagen (http://pepcalc.com/). To check the purity, 
NLS peptides were loaded and subjected to electrophoresis (100 V, 2h) in a 12% sodium 
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2.3. Polyplex preparation 
 
 
To test non-viral formulations of chitosan/DNA polyplexes with NLS peptides, we have 
used different methodologies: co-administration of polyplexes and peptides at the time 
of transfection, covalent ligation of NLS peptides to chitosan, and co-complexation, by 
adding the NLS peptides at the time of chitosan-DNA polyplex formation. A summary of 
the produced formulations is shown in table II.  
To prepare chitosan-DNA polyplexes, DNA was diluted in 500 µl of a sodium sulfate 
solution (25 mM) and an equal volume of CS solution was preheated to 55°C for 5 min 
to prevent aggregation upon polyplex formation [32]. Both solutions were quickly mixed 
together, placed on ice for 30 min and stored at 4°C. Different amounts of NLS peptides 
(10, 25, 50, 100 and 150 µg for NLS-3 and 10, 25 and 50 µg for NLS-5) were co-
administrated with this formulation (CS) at the time of the in vitro transfection. The N:P 
ratio (amines from CS and P from DNA) was 15:1. 
To test if polyplexes were affected by the presence of salts, the DNA solution was not 
diluted into the sodium sulfate solution, and polyplexes were prepared by adding the 
DNA solution directly to the CS solution either in the presence (CS3 and CS5) or absence 
(CS0) of NLS peptides. The total amount of NLS peptides was either added to the CS 
solution [CS3 (T), CS5 (T)] or split into equal parts and added to each solution [CS3 (S), 
CS5 (S)] which were then quickly mixed as described above. Different amounts of NLS 
peptides were tested (10, 50 and 100 µg). 
To test for differences in complexation efficiency, polyplexes were prepared considering 
the total amount of amine groups, adding those of NLS peptides and chitosan, at the 
same N:P ratio of 15:1. These formulations were prepared in the same way as described 
for the previous polyplexes (CS3 and CS5, S and T). For these formulations (15:1CS3 
and 15:1CS5), a fixed peptide amount of 100 µg was chosen. 
We have also covalently linked the NLS peptides to chitosan, by using a one and a half 
molar excess (relative to the carboxylic acid groups in the peptides) of N-(3-
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NLS peptides and stirred at 4ºC for 24h. The mixture was then added to chitosan and 
polyplexes (formulations CSedac3 and CSedac5) prepared as described above and 
stored at 4ºC. 
Table II: Polyplex formulations. CS – chitosan; N – nitrogen (representing amine groups); 
P – Phosphate (representing DNA); T – NLS added to CS solution; S – NLS split between 
CS and DNA solutions. For formulation CS (chitosan), Na2SO4 was added to form the 
polyplexes. 
 
Formulation NLS Strategy 
CS0 No N : P = 15:1 
CS No N : P = 15:1 
Co-administration of polyplexes and NLS 
peptides (NLS-3: 10, 25, 50, 100 µg; NLS-5: 
10, 25 and 50 µg) 
CS3(T) NLS-3: 10, 50 and 100 µg N : P = 15:1 
Co-complexation. NLS added to CS solution 
CS5(T) NLS-5: 10, 50 and 100 µg N : P = 15:1 
Co-complexation. NLS added to CS solution 
CS3(S) NLS-3: 10, 50 and 100 µg N : P = 15:1 
Co-complexation. NLS split between CS and 
DNA solutions 
CS5(S) NLS-5: 10, 50 and 100 µg N : P = 15:1 
Co-complexation. NLS split between CS and 
DNA solutions 
15:1-CS3T NLS-3: 100 µg N (CS+NLS) : P = 15:1 
Co-complexation. NLS added to CS solution 
15:1-CS5T NLS-5: 100 µg N (CS+NLS) : P = 15:1 
Co-complexation. NLS added to CS solution 
15:1-CS3S NLS-3: 100 µg N (CS+NLS) : P = 15:1 
Co-complexation. NLS split between CS and 
DNA solutions 
15:1-CS5S NLS-5: 100 µg N (CS+NLS) : P = 15:1 
Co-complexation. NLS solution split between 
CS and DNA solutions 
CSedac3 NLS-3: 100 µg N (CS+NLS) : P = 15:1 
NLS covalently linked to CS 
CSedac5 NLS-5: 100 µg N (CS+NLS) : P = 15:1 
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2.4. Polyplex characterization 
 
Polyplex size measurements were performed with dilution in ddH2O water by dynamic 
light scattering (DLS), at 25ºC with a detection angle of 173º, using a Zetasizer Nano ZS 
(Malvern Instruments, UK) and zeta potential (surface charge) measured with laser 
Doppler velocimetry. 
 
2.5. Polyplex complexation efficiency 
 
DNA complexation efficiency by the polyplexes was assessed using a gel retardation 
assay. Agarose gels were prepared in TAE buffer (1% w/v) and visualized using 
GreenSafe® Premium (NZYtech, Portugal). Polyplex formulations and a 1kb DNA 
marker (New England Biolabs, EUA) were loaded in each well and electrophoresis was 
carried out for approximately 60 minutes at +90 mV, with samples visualized under an 
UV light. 
 
2.6. NLS influence on cell viability 
 
To evaluate the effect of NLS-3 and NLS-5 peptides on HEK293T cell viability, an MTT 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay was performed. 
Cells were seeded in a 48-well plate at a density of 15 000 cells per well with 500 µl of 
complete DMEM (supplemented with FBS, pen-strep) and allowed to grow for 24 hours, 
at 37ºC under a 5% CO2 atmosphere. Culture medium was then replaced by serum-free 
DMEM containing different amounts of NLS-3 (0, 10, 25, 50, 100 µg) and NLS-5 (0, 10, 
25, 50 and 100 µg) incubated for 5 hours, and then replaced by complete DMEM until 
analysis. 
For the cytotoxicity evaluation, the cell culture medium was removed and replaced by 25 
µl of MTT solution (5 mg/ml in PBS) and cells were further incubated for 4 hours. To 
solubilize the formed formazan crystals, 250 µl of a 0.04 N HCl in isopropanol solution 
was added to each well. After one hour, the absorbance was measured on a microplate 
reader (Tecan Infinite M200, USA) at 570 nm for formazan quantification, and at 630 nm 
for cellular debris. Non-treated cells (0 µg of NLS peptides) were used as positive control, 
and cells treated with latex extract were used as negative control for cell viability. Cell 
viability was calculated using the following equation: 
Sample absorbance = absorbance at 570 nm - absorbance at 630 nm 
Cell viability (%) = (sample absorbance / positive control absorbance) × 100 
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2.7. In vitro transfection assays 
 
Cells were seeded at a density of 200 000 cells per well in 6-well culture plates with 
DMEM supplemented with FBS at 37ºC under a 5% CO2 atmosphere. 24 hours after cell 
seeding, the formulations, prepared as described in section 2.3, were added to the cells, 
and followed the experimental setup described in the previous section. All formulations 
were added to the cells in a single step, except for the co-administration condition, where 
the polyplexes were added to the cells first, followed by different amounts of NLS-3 and 
NLS-5 peptides. Transfection efficiency was assessed qualitatively using a fluorescence 
microscope (Axiovert 40 CFL, Zeiss, Germany) for GFP expression at 48h and 72h post-
transfection, and quantitatively by flow cytometry (FACSCalibur, BD Biosciences, USA). 
For the latter, cells were washed thrice and re-suspended in PBS for analysis of GFP 
expression, with a total of 50,000 events counted for each sample. All experiments were 
performed in triplicate. 
 
2.8. Statistical analysis 
 
Statistical analysis was performed using Prism 6 (GraphPad Software), and 
statistical significance was analyzed by one-way ANOVA with multiple comparison tests 
or by an Unpaired t-test with Welch’s correction using a confidence interval of 95% and 
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Results & Discussion 
 
3.1. Polyplex formulations display properties adequate for gene transfer 
 
A positive surface charge is required for efficient cellular uptake since cell entry occurs 
by non-specific electrostatic interactions between the positively charged polyplexes and 
the negatively charged cell surface [33]. Parameters as N:P ratio, molecular weight, 
mixing technique, among others, have been widely investigated on CS-DNA complexes 
[32, 34-36], and described as factors that influence the binding affinity between chitosan 
and DNA, size and charge of polyplexes, cellular uptake and dissociation of DNA, and 
thus, transfection efficiency [37-39]. Based on our previous work [10-14], an amine to 
phosphate (N:P) ratio of 15:1 was chosen to promote the formation of positively charged 
polyplexes and avoid repulsion by the negative cell surface. 
The preparation method of chitosan-Dd by solubilizing DNA in a Na2SO4 solution and 
mixing with a chitosan solution [32]. ENA polyplexes was adapted from Mao et al, where 
polyplexes were preparelectrostatic interactions between positively charged amine 
groups (of chitosan) and negatively charged phosphate groups (of DNA) is the known 
driver for polyplex formation. This preparation method yielded homogeneous 
formulations (CS), with polydispersity below 0.3, mean size of 285.85 ± 56.50 nm and 
positively charged, with mean values of zeta potential of 15.45 ± 0.21 mV. 
The effect of salt addition in the coacervation of polyelectrolytes (salting-out) is well 
known [40-42]. This effect has been correlated to the chaotropic/kosmotropic nature of 
the salt ions, contributing to phase separation by removal of the water layer around the 
dissolved macromolecules [32], to a greater or lesser extent, according to the Hofmeister 
series. However, it is not very likely that even strongly hydrated ions significantly 
influence water beyond their immediate solvation shells, and therefore the solute itself 
needs to be considered [43]. It is indeed more likely that this effect is a result of charge 
screening, where salt ions interact with the polyelectrolytes, providing local charge 
compensation for the charge imbalance and favoring more accessible polymer 
conformations, thus promoting chain entanglement [42]. Since Mao et al, observed that 
the presence of sodium sulfate within the range 2.5 - 25 mM did not significantly affect 
the mean size of CS/DNA polyplexes, in order to evaluate the effect of salt addition in 
the properties of the prepared polyplexes, this solution was completely removed from 
polyplex preparation [32]. 
Polyplexes prepared in the absence of sodium sulfate (formulation CS0) presented an 
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± 10.43 mV. This may be ascribed to stiffer chain conformations of both polyelectrolytes, 
due to the low ionic strength of the medium, creating obstacles to an effective chain 
entanglement and charge neutralization. 
Using this preparation method, different amounts of NLS peptides (10, 50 and 100 μg) 
were co-complexed with polyplexes using two different approaches: the total amount of 
each NLS peptide added solely to the chitosan solution [formulations CS3 (T) and CS5 
(T), with T for total] or divided into 2 equal parts and each part added to either the 
chitosan or DNA solutions [formulations CS3 (S) and CS5 (S), with S for split], as 
described in the methodology section. NLS-3 and -5 are 18 amino acid peptides bearing 
10 positively charged residues (arginine and lysine) intercalated with neutral ones, a six 
histidine residues tag, which is partially protonated (~78% at pH 5.5), the N-terminal 
ammonium group and the C-terminal carboxylate. With molecular weights of 3 kDa, their 
charge/mass ratio is approximately 5 x 10-3, practically the same as 83% deacetylated 
CS, with an average molar mass of 168 g/mol and a 0.83 positive charge per monomer. 
Therefore, the total N:P ratio in CS-3 and CS-5 formulations are approximately 15.5:1, 
16.5:1 and 18:1 for the addition of 10, 50 and 100 μg, respectively. 
These polyplexes were characterized regarding their size, polydispersity, and zeta 
potential, as shown in a representative figure (Figure 1) for S (Split for NLS split between 
chitosan and DNA solutions) and T (Total NLS added to chitosan) formulations. There 
seems to be a trend for size reduction with increasing NLS concentration, although not 
to a statistically significant extent, except for the two highest concentrations of NLS-5. A 
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Figure 1 – Physical characterization of CS3 and CS5 polyplexes. 
Size (graph A) and Zeta Potential (graph B) of CS3 and CS5 polyplexes. The white bar 
represents the CS polyplexes without NLS. The graphs are representative for S and T 
formulations, as no differences were found between these formulations. Polydispersity 
was similar for all samples (below 0.4). Statistical differences, compared to polyplexes 
without NLS peptides (0) were calculated using Dunnett’s multiple comparisons test 
(N=3, error bars=SD; **p<0.01; *p<0.05). 
 
 
Being relatively small molecules and containing positively charged groups dispersed 
throughout the backbone, NLS may have a bridging or reticulating effect during polyplex 
formation, leading to lower polyplex sizes. Another possibility is a competition between 
these molecules and CS for the negatively charged DNA chains, leading to the 
replacement of some CS chains in polyplexes and to more reduced sizes. The more 
significant effect of NLS-5 may be attributed to its higher arginine content: contrary to 
lysine, whose ammonium groups may be self-solvated by the carbonyl oxygen atoms of 
amides when sterically possible and therefore unavailable for salt bridging, the large 
guanidinium group of arginine, with an extensive delocalized charge, is less prone to 
self-solvation, hence more available for ion pairing [44]. Nevertheless, the addition of 
NLS seems to not affect zeta potential, which is consistent with both the above 
possibilities, as entrapment of NLS inside the polyplexes or replacement of CS chains 
by the peptide would not drastically change the surface charge. 
 
Since the mixing method can influence the properties of polyplexes [37], we evaluated if 
adding the total amount of NLS peptides to the chitosan solution or adding it in equal 
amounts to either the chitosan or DNA solutions had an impact on polyplex formation. 
Because NLS, like CS, are positively charged, a competition between the two types of 
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to polyplex formation, the inclusion of NLS in the formulations is guaranteed, either by 
formation of soluble complexes or even small coacervate particles [45], which will grow 
upon addition of CS and the remaining NLS. In this way, we expect to have some NLS 
chains at the surface of polyplexes, in case polyplexes approach the nucleus still intact, 
and also near the plasmid, in case polyplex degradation starts during lysosomal escape 
and only DNA reaches the nucleus. We have tested all conditions and selected a 




Figure 2 – Comparison of physical properties of CS3 (S and T) and CS5 (S and T) 
polyplexes. 
Size (graph A) and Zeta Potential (graph B) of CS3 (S) and CS3 (T), and CS5 (S) and 
CS5 (T) co-complexation polyplexes, with 100 µg of NLS-3 and NLS-5 peptides, 
respectively. Polydispersity was similar for all samples (below 0.4). Statistical differences 
between polyplexes with the same NLS peptide were calculated using Sidak’s multiple 
comparisons test. No differences were found between formulations. N=3. Error bars refer 
to standard deviation. 
 
 
Despite a slight increase in polyplex mean size observed for (T) formulations compared 
to (S) formulations, no statistical differences were found for either NLS-3 or NLS-5 
peptides. This increasing trend may be justified by the early interaction between DNA 
chains and NLS, which may have facilitated charge pairing during polyplex formation. 
The surface charge was also similar among formulations (Figure 2), indicating that the 
process of NLS addition does not significantly influence the physical properties of 
polyplexes. 
 
To test for a possible effect in polyplex formation of the additional amount of positive 
charges brought by the addition of the NLS peptides in formulations CS-3 and CS-5, the 
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considering the total amount of positively charged groups, including peptide and polymer, 
at a (NLS-3+CS):DNA or (NLS-5+CS):DNA (N:P ratio) of 15:1 and further characterized 
(Figure 3). Again, the addition of NLS was either totally made to the CS solution (T 













Figure 3 – Comparison of physical properties of CS0, CS3, CS5, 15:1-CS3, 15:1-
CS5, CSedac3 and CSedac5. 
Size (graph A) and Zeta Potential (graph B) of polyplexes CS0, CS3, CS5, 15:1-CS3, 
15:1-CS5, all with 100 µg of NLS (the graphs are representative for S and T co-
complexation formulations) and covalently bond NLS formulations (CSedac3 and 
CSedac5).Polydispersity was below 0.4. Statistical differences of each condition 
compared to polyplexes without NLS peptides (CS0) were calculated using Dunnett’s 




Other than co-administration and co-complexation of NLS with polyplexes, we have also 
covalently linked the NLS to polyplexes. Several methods have been described in the 
literature to covalently bind NLS peptides to DNA:Ciolina et al. covalently associated 
NLS peptides to DNA by photoactivation, but these plasmid-NLS conjugates were not 
detected in the nucleus [46]; others have observed an increase on gene expression only 
when five NLS peptides were covalently coupled to DNA by diazo coupling through a 
PEG chain but not when the NLS peptides were directly coupled to DNA [47]; Zanta and 
colleagues covalently ligated one NLS-oligonucleotide to one or both ends of a linear 
DNA [48]. However, extensive chemical modification of DNA causes reduction or 
inhibition of gene expression [16, 22, 47, 49]. Therefore, to avoid the chemical 
modification of DNA, we have covalently linked NLS peptides to chitosan. This was 
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attack of CS amine groups. This strategy produced polyplex formulations CSedac3 and 
CSedac5, with physical properties as shown in figure 3 (size graph). 
These polyplex formulations presented sizes larger than all other NLS formulations, and 
closer to those of the NLS free formulation, CS0. One possible explanation is the 
involvement of the carboxylate group in salt bridges with the ammonium and guanidium 
groups of lysine and arginine residues [44], thus less available for reaction. However, if 
it was the case, unreacted NLS would still be present and these formulations would 
resemble 15:1-CS3 and 15:1-CS5. Therefore, it is most likely that bonding occurred and 
that once linked to the CS chain, NLS are not able to play the same role as when they 
are added to the formulation in a free state. We had expected the surface charge to be 
of the same magnitude as other formulations with NLS, and that is confirmed (as 
observed in Figure 3, in the zeta potential graph). 
 
The efficiency of cellular uptake and intracellular trafficking depends on the physical 
characteristics of polyplexes. A survey of the literature shows that larger particles get 
internalized less often than smaller particles but have a higher rate of gene release into 
the cytosol due to their prolonged residence time. This prolonged residence time is an 
indication that larger particles most likely avoid rapid lysosomal degradation. Particles 
with sizes from 200 nm to 1 µm are internalized mainly by caveolae-mediated 
endocytosis [50, 51], and the motility of caveolae is relatively low, depending on the 
network of actin filaments and microtubules [52]. Considering all our polyplexes have a 
size distribution ranging from 250 to 750 nm, based on the literature, the predominant 
internalization pathway for our polyplexes is considered to be caveolae-mediated 
endocytosis. The surface charge also affects cellular uptake of polyplexes, and 
according to the literature, positively charged polyplexes interact efficiently with the cell 
membrane [38]. All formulations in our study are positively charged polyplexes, thus 
favoring internalization. 
 
DNA complexation in polyplex formulations was evaluated by agarose gel 
electrophoresis. DNA complexation was effectively achieved for all formulations, 
confirmed by the absence of free DNA migration in the gel (supplementary figure S2), 
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3.2. NLS are cytocompatible 
 
The cytotoxicity of NLS peptides was evaluated at 24h and 72h using HEK293T cells 
and the MTT assay, as depicted in figure 4. No cytotoxicity was observed for either NLS-
3 and NLS-5 peptides regardless of the amount, since cell viability was above 90% for 
all tested concentrations. 
 
 
Figure 4 – Cell viability evaluation of NLS peptides. 
Cell viability (%) after 24h and 72h of incubation with different amounts of NLS-3 (graphs 
A, B) and NLS-5 (graphs C, D) peptides. Untreated cells were used as positive viability 
control (0 µg) and cells incubated with latex extracts as negative viability control (C-). 
Statistical differences, compared to positive control (0 µg), were calculated using 
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3.3. Improvement in transfection efficiency is NLS and method dependent 
 
The transfection efficiency of all formulations was evaluated in HEK293T cells, which is 
a commonly used cell line for transfection studies. The gene transfer efficiency of the 
different NLS incorporation strategies was evaluated by GFP expression, visualized by 
fluorescence microscopy after 48h and 72h (supplementary data), and quantitatively 





3.3.1. Co-administration of polyplexes and NLS does not improve transfection 
efficiency 
 
To evaluate the transfection efficiency of NLS co-administered with polyplexes the 
formulation CS0 and NLS solution were simultaneously added at the time of transfection. 
For NLS-3 peptide amounts between 10 and 150 µg were co-administrated and for NLS-
5 the range varied between 10 and 50 µg, since no improvement was observed with 
higher concentrations of peptides in preliminary studies [53]. 
The in vitro transfection ability of CS polyplexes without NLS peptides (Figure 5) was 
relatively low, reaching 25% transfection efficiency. Similar results were achieved in a 
study with the same preparation method of polyplexes in HEK293T cells, where a low 
transfection efficiency of chitosan/DNA complexes was obtained [32]. 
Contrary to what has been described in the literature for other NLS, no increase in 
transfection efficiency was observed when either peptide was co-administered with CS0 
polyplexes, regardless of the amounts of NLS (Figure 5: conditions 10, 25, 50, and 100 
µg), when compared with polyplexes without NLS peptides (Figure 5, condition 0 µg). 
Moreover, polyplexes with IGFBP-5 peptides registered a significant decrease in 
transfection when compared with polyplexes without NLS peptides. In spite of polyplexes 
having size and surface charge appropriate for gene delivery, and the cationic NLS 
peptides containing lysine and arginine and thus being capable of binding to DNA 
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Figure 5 – Transfection efficiency after co-administration of polyplexes with NLS-
3 and NLS-5. 
Transfection efficiency expressed as percentage of GFP-positive cells after co-
administration of polyplexes (CS) with NLS-3 (graph A and dot plot A’) or NLS-5 (graph 
B and dot plot B’). Transfection was performed with 1 µg of DNA for all groups and 
analyzed 72h after transfection. N=3, bars correspond to SD. Statistical significance was 
tested by one-way ANOVA with Dunnett’s post-test compared against polyplexes without 
NLS peptides (0 µg) (**p<0.01).  
 
 
3.3.2. Co-complexation of polyplexes and NLS improves transfection efficiency 
 
 
NLSs can be coupled to DNA or to vectors to improve gene delivery but it is not yet clear 
what is the best method to incorporate the NLS peptides [54]. Yoo et al attached 
psoralen-NLS conjugates non-covalently to DNA/PEI complexes and observed an 
increase in transfection efficiency in COS-1 cells when compared to a mutant NLS or 
DNA/PEI complexes without NLS peptides [49]. Other authors incorporated NLS 
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increasing ratio of co-complexed NLS peptides increased the transfection efficiency in 
HeLa cells, in a NLS-dose dependent manner [22]. 
We have therefore prepared polyplexes by co-complexation of chitosan, DNA, and 
increasing amounts of NLS-3 and NLS-5 peptides. To test if the NLS incorporation 
strategy influenced the transfection efficiency, we have prepared polyplexes with total 
NLS added to chitosan [CS3 (T), CS5 (T)] and NLS equally divided between chitosan 
and DNA solutions [CS3 (S), CS5 (S)]. GFP expression was quantified as shown in 
Figure 6, which is representative of both strategies (total and split). 
 
Figure 6 – Transfection efficiency of CS3 and CS5 co-complexation polyplexes. 
Transfection efficiency expressed as percentage of GFP-positive cell for CS3 (S) (graph 
A and dot plot A’) and CS5 (S) (graph B and dot plot B’) co-complexation polyplexes. 
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transfection. N=3, bars correspond to SD. Statistical differences were calculated using 
Dunnett’s multiple comparisons test compared with polyplexes without NLS peptides (0 




A significant increase in transfection efficiency was observed with polyplexes co-
complexed with NLS-3 peptides when compared to polyplexes without NLS (CS, 0 µg). 
Contrary to what was expected, this trend was not observed in polyplexes co-complexed 
with NLS-5 peptides. This was observed for both incorporation strategies (total and split) 
and although this had an effect on the size of polyplexes (Figure 2), it does not appear 
to affect their efficiency, as reported for other systems [37]. 
Previous studies reported that the affinity or accessibility to importin subunits differ 
between IGFBP-3 and IGFBP-5, although it is not clear how [26]. This could explain the 
difference in the results of Figure 6. When NLS-5 peptides are co-complexed with CS 
polyplexes, the accessibility of the peptides to their nuclear receptors (i.e. importins) 
might be hampered and DNA nuclear delivery is lower, hence no improvement in 
transfection efficiency is observed. 
 
Although the addition of NLS peptides did not significantly alter the size or surface charge 
of polyplexes, we have nonetheless tested if formulations accounting for NLS charge 
addition (15:1-CS3 and 15:1-CS5) had an impact in transfection efficiency (Figure 7). 
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Figure 7 – Transfection efficiency of 15:1-CS3 and 15:1-CS5 co-complexation 
polyplexes. 
Transfection efficiency expressed as percentage of GFP-positive cells by 15:1-CS3 (S) 
and (T) (graph A and dot plot A’) and 15:1-CS5 (S) and (T) (graph B and dot plot B’) co-
complexation polyplexes with 100 µg of NLS peptides. Transfection was performed with 
1 µg of DNA for all groups and analyzed 72h after transfection. N=3, bars correspond to 
SD. Statistical differences compared with CS polyplexes (condition 0 in both graphs) 
were calculated using Dunnett’s multiple comparisons test (****p<0.0001).  
 
The effect of N:P ratio of polyplexes has been widely investigated [19, 20, 22, 32, 37] 
and described as influencing polyplex formation (size and surface charge) and 
transfection efficiency [38]. In this work, the amount of chitosan was adjusted to include 
peptides in the N:P ratio and therefore to maintain the number of amine groups available 
for interaction with the DNA. Hence, the statistically significant 2-fold increase in 
transfection efficiency observed for 15:1CS3 polyplexes, (S) and (T), when compared 
with polyplexes without NLS peptides (condition 0, figure 7, graph A) is attributed to the 
presence of NLS. For polyplexes with NLS-5 peptides, no increase in transfection 
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3.3.3. Covalent ligation of NLS to polyplexes improves transfection efficiency 
 
The third method chosen for the incorporation of NLS peptides was covalent ligation. 
Several methods for covalently linking molecules to DNA have been developed [46-48, 
55] but the chemical modification of DNA might cause a decrease in its transcription [16, 
49]. In this study, we have therefore chosen to covalently link NLS peptides to the 
polymer. This was performed via amide bond formation between the carboxylic acid 
moieties of the NLS peptides and the amine groups of chitosan, which was mediated by 
a carbodiimide (EDAC). Resulting polyplexes were also tested for their transfection 
efficiency, as shown in Figure 8. 
 
Figure 8 – Transfection efficiency of CSedac3 and CSedac5 polyplexes. 
Transfection efficiency represented by percentage of GFP-positive cells of CSedac3 
(graph A and dot plot A’) and CSedac5 (graph B and dot plot B’) polyplexes covalently 
linked with 100 µg of NLS peptides. Transfection was performed with 1 µg of DNA for all 
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differences compared with CS polyplexes were calculated using an Unpaired t test with 
Welch’s correction (*p<0.05).  
 
  
In figure 8 a 2-fold enhancement in the transfection efficiency of CSedac3 polyplexes is 
observed when compared to polyplexes without NLS peptides. Again, no increase in 
transfection efficiency was observed for CSedac5 polyplexes compared to polyplexes 
without NLS peptides. These results indicate that transfection efficiency is improved by 
polyplexes with IGFBP-3 peptides but not with polyplexes with IGFBP-5 peptides, 
suggesting, as hypothesized above, that recognition of IGFBP-5 peptides by importins 
may be hampered by their entanglement during polyplex preparation. This is supported 
by the results for polyplex size, which are smaller for formulations with IGFBP-5 peptides, 
a reflection of a higher degree of entanglement. 
When compared with the other two methodologies (co-administration and co-
complexation) CSedac3 and CSedac5 polyplexes yielded similar transfection 





The goal of this study was to determine if the transfection efficiency of chitosan-based 
non-viral gene delivery systems can be improved through the incorporation of NLS 
peptides. We have tested three approaches to incorporate the IGFBP-derived NLS 
peptides into polyplexes: co-administration at the time of transfection, co-complexation 
during polyplex production and covalent ligation to the polymer component prior to 
polyplex preparation. The characterization of the resulting formulations has shown that 
sodium sulfate has a role in polymer-DNA entanglement, since its addition yielded 
polyplexes with smaller size and surface charge.  
We have also observed that the addition of increasing amounts of NLS peptides to 
polyplexes influenced their physical properties, such as size and surface charge, which 
were NLS dependent. However, regardless of the incorporation technique, the presence 
of sodium sulfate, N:P ratio, or addition of NLS peptides, all polyplex formulations were 
positively charged, capable of effective DNA complexation and with a size suitable for 
their use for gene delivery. The NLS peptides were not cytotoxic to HEK293T cells and 
lastly, in vitro transfection assays showed that transfection efficiency of polyplexes was 
dependent on the NLS peptide and incorporation strategy. Co-administration of the 
polyplexes and NLS-5 showed no improvement in transfection efficiency. On the other 
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increase in transfection efficiency, most likely due to higher affinity with or accessibility 
to importin subunits between NLS-3 and NLS-5 peptides. 
To the best of our knowledge, this is the first study where NLS peptides derived from 
human molecules are associated to chitosan-based non-viral gene vectors. Overall the 
results show that polyplexes co-complexed with NLS-3 peptides are indeed good 
candidates for non-viral gene delivery systems. Further studies will include their 
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